New England Journal of Medicine· 2017Q1
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients
- 2,993citations
- Q1SCImago
- 2017year
Short summary
Transcatheter aortic-valve replacement (TAVR) was non-inferior to surgical aortic-valve replacement in intermediate-risk patients with severe aortic stenosis, with a composite endpoint of death or disabling stroke at 24 months occurring in 12.6% of TAVR patients vs. 14.0% of surgery patients.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Cardiology and Cardiovascular Medicine
Cardiology and Cardiovascular MedicineMedicine